Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: A grading algorithm versus blinded expert panel review

Go back to Resources

Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: A grading algorithm versus blinded expert panel review

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Prograf as secondary intervention vs continuation of cyclosporine in patients at risk for chronic renal allograft failure (CRAF) results in improved renal function, decreased CV risk, and no increased risk for diabetes

Go back to Resources

Prograf as secondary intervention vs continuation of cyclosporine in patients at risk for chronic renal allograft failure (CRAF) results in improved renal function, decreased CV risk, and no increased risk for diabetes

Authors:

Location:

Go back to Resources

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

Go back to Resources

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Palivizumab prophylaxis of RSV disease: demographic and risk factors results from the 2002-2003 Outcomes Registry

Go back to Resources

Palivizumab prophylaxis of RSV disease: demographic and risk factors results from the 2002-2003 Outcomes Registry

Authors:

Location:

Go back to Resources

Palivizumab prophylaxis of respiratory syncytial virus (RSV) - results from the 2000-2001 Synagis Outcomes Registry

Go back to Resources

Palivizumab prophylaxis of respiratory syncytial virus (RSV) - results from the 2000-2001 Synagis Outcomes Registry

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Ongoing Prospective Multi-Center Safety Study of Subcutaneous Cytoprotectant Amifostine

Go back to Resources

Ongoing Prospective Multi-Center Safety Study of Subcutaneous Cytoprotectant Amifostine

Authors:

Location:

Go back to Resources

Not simply a matter of faulty memory: obstacles to implementing cognitive function ancillary studies in clinical trials with other primary outcomes

Go back to Resources

Not simply a matter of faulty memory: obstacles to implementing cognitive function ancillary studies in clinical trials with other primary outcomes

Authors:

Location:

Go back to Resources

No Changes in Immune Activation Phenotypes, Response to Antigen, or CD8+ T-cell Mediated HIV Suppression in Transplant Recipients Receiving Immunosuppression

Go back to Resources

No Changes in Immune Activation Phenotypes, Response to Antigen, or CD8+ T-cell Mediated HIV Suppression in Transplant Recipients Receiving Immunosuppression

Authors:

Location:

Go back to Resources

No Benefit of 1log T-cell Depletion on Chronic Graft vs Host Disease (cGVHD):Results of a Multi-Center Randomized Trial in 404 Recipients of Unrelated Donor Bone Marrow Transplantation (UBMT)

Go back to Resources

No Benefit of 1log T-cell Depletion on Chronic Graft vs Host Disease (cGVHD):Results of a Multi-Center Randomized Trial in 404 Recipients of Unrelated Donor Bone Marrow Transplantation (UBMT)

Authors:

Location:

Go back to Resources

National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS). AREDS Report No. 10

Go back to Resources

National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS). AREDS Report No. 10

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Subscribe to